Title |
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial / Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Markus Eckstein, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Max Schlaak, Kai-Martin Thoms, Selma Ugurel, Jochen Utikal, Michael Weichenthal, Beatrice Schuler-Thurner, Carola Berking, Markus V. Heppt |
---|---|
Involved |
Elias A. T. Koch (Verfasser)
Anne Petzold (Verfasser) Anja Wessely (Verfasser) Edgar Dippel (Verfasser)
Markus Eckstein (Verfasser)
Anja Gesierich (Verfasser) Ralf Gutzmer (Verfasser) Jessica C. Hassel (Verfasser) Harald Knorr (Verfasser) Nicole Kreuzberg (Verfasser) Ulrike Leiter (Verfasser) Carmen Loquai (Verfasser) Friedegund Meier (Verfasser) Markus Meissner (Verfasser) Peter Mohr (Verfasser) Claudia Pföhler (Verfasser) Farnaz Rahimi (Verfasser) Dirk Schadendorf (Verfasser) Max Schlaak (Verfasser) Kai-Martin Thoms (Verfasser) Selma Ugurel (Verfasser) Jochen Utikal (Verfasser) Michael Weichenthal (Verfasser) Beatrice Schuler-Thurner (Verfasser) Carola Berking (Verfasser) Markus V. Heppt (Verfasser) |
Published |
Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
uveal melanoma
liver-directed therapy immune checkpoint blockade SIRT
anti-PD-1
anti-CTLA-4 Medical and Health Sciences |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2411080446324.429307024978 (URN) |
Further information |
In: Frontiers of Medicine 17.5 (2023). DOI:10.1007/s11684-023-0993-y |
Record ID |
1347617159 |
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: